A class action over birth defects linked to the morning sickness drug thalidomide was settled in an Australian court this Monday, with the British distributor agreeing to pay victims Aus$89 million (Rs 500,71,40,000).
Lawyers representing some 100 Australian and New Zealand victims of the drug told the Victorian Supreme Court that settlement had been reached with Diageo, which owns now-defunct thalidomide distributor The Distillers Company. “It’s been a long time coming,” lawyer Peter Gordon told the court.
The $89 million payout, signals an end to the case with Gordon indicated that an associated compensation suit again German drug manufacturer Grunenthal would be abandoned.
Thalidomide was launched in the late 1950s and was sold in nearly 50 countries before it was withdrawn after babies began showing severe side effects from the drug.
An estimated 10,000 children worldwide were born with deformities, including the absence of arms and legs.AFP